According to Sientra's latest financial reports and stock price the company's current Operating Margin is -70.63%. At the end of 2021 the company had an Operating Margin of -77.46%.
Year | Operating Margin | Change |
---|---|---|
2021 | -77.46% | -38.63% |
2020 | -126.21% | -1.07% |
2019 | -127.58% | 5.19% |
2018 | -121.29% | -30.8% |
2017 | -175.26% | -9.39% |
2016 | -193.43% | 78.77% |
2015 | -108.20% | 732.91% |
2014 | -12.99% | -76.11% |
2013 | -54.38% | -75.76% |
2012 | -224.30% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 31.50% | -144.60% | ๐บ๐ธ USA |
iRadimed IRMD | 30.93% | -143.79% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | -15.72% | -77.74% | ๐บ๐ธ USA |
West Pharmaceutical WST | 21.20% | -130.02% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.